Lamictal combined with Levothyroxine Sodium

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Weight Decreased Required Intervention 11/1/2004 78 Male 115 lb 1/3/2006 Consumer United States
Primary
Concomitant
Pancreatitis Acute Hospitalization 10/20/2005 41 Female 166 lb 1/6/2006 Other Health Professional United States
Primary
Secondary
Concomitant
Sunburn 3/8/2005 51 Female 2/28/2006 Consumer United States
Primary
Concomitant
Rash 6/3/2005 55 Female 165 lb 2/28/2006 Consumer United States
Primary
Secondary
Concomitant
Abdominal Pain Upper 11/1/2005 31 Female 220 lb 2/2/2006 United States
Primary
Concomitant
Uterine Disorder Other Serious 1/1/2001 55 Female 161 lb 5/3/2006 Physician United States
Primary
Concomitant
Pneumonia Other Serious 4/1/2006 36 Female 5/26/2006 Consumer United States
Primary
Concomitant
No Adverse Effect 31 Female 220 lb 5/5/2006 Consumer United States
Primary
Concomitant
Urinary Tract Infection Other Serious 4/1/2001 Male 205 lb 6/30/2006 United States
Primary
Secondary
Concomitant
Injection Site Pruritus Other Serious 5/23/2006 23 Male 112 lb 7/4/2006 Physician France
Primary
Concomitant
Treatment Noncompliance Other Serious 1/1/2006 65 Male 130 lb 9/29/2006 United States
Primary
Secondary
Concomitant
Weight Decreased Hospitalization 7/1/2006 52 Female 230 lb 10/9/2006 Consumer United States
Primary
Secondary
Concomitant
Headache 8/30/2004 Female 8/22/2006 Physician United States
Primary
Concomitant
Vasospasm Hospitalization 10/5/2006 56 Female 165 lb 11/7/2006 Physician Canada
Primary
Secondary
Concomitant
Somnolence Other Serious 8/16/2006 51 Female 112 lb 11/6/2006 Physician France
Primary
Secondary
Concomitant
Thrombocytopenia Other Serious 8/16/2006 51 Female 112 lb 11/7/2006 Physician France
Primary
Secondary
Concomitant
Hypotonia Neonatal Hospitalization 1/1/2006 Female 12/7/2006 Consumer France
Primary
Concomitant
Visual Disturbance Other Serious 1/1/2006 51 Female 12/21/2006 Consumer United States
Primary
Concomitant
Pseudolymphoma Hospitalization 1/15/2004 59 Female 1/15/2007 Consumer France
Primary
Secondary
Drug Interaction Other Serious Male 317 lb 1/23/2007 United States
Primary
Secondary
Weight Increased Other Serious 1/1/2005 Female 163 lb 1/23/2007 Consumer United States
Primary
Concomitant
Pseudolymphoma Hospitalization 1/15/2004 62 Female 1/16/2007 Other Health Professional France
Primary
Secondary
Tongue Ulceration 9/1/2004 74 Male 2/28/2007 Consumer United States
Primary
Concomitant
Nausea 11/1/2005 58 Female 2/28/2007 Consumer United States
Primary
Concomitant
Rash 2/13/2006 51 Female 2/28/2007 Consumer United States
Primary
Concomitant
Ecchymosis 2/1/2006 7 Female 2/28/2007 Consumer United States
Primary
Concomitant
Coordination Abnormal 3/1/2006 66 Male 2/28/2007 Consumer United States
Primary
Concomitant
Mucosal Inflammation 2/1/2006 Female 2/28/2007 Consumer United States
Primary
Secondary
Concomitant
Rash Hospitalization 1/1/2005 72 Female 2/28/2007 Consumer United States
Primary
Concomitant
Vomiting Hospitalization 6/18/2006 35 Female 2/28/2007 Consumer United States
Primary
Concomitant
Somnolence 8/20/2006 48 Female 2/28/2007 Consumer United States
Primary
Concomitant
Rash 8/1/2006 50 Female 2/28/2007 Consumer United States
Primary
Concomitant
Prescribed Overdose Other Serious Female 3/8/2007 Consumer United States
Primary
Concomitant
Weight Increased Other Serious 1/1/2005 Female 163 lb 3/16/2007 Consumer United States
Primary
Concomitant
Superinfection Hospitalization 2/22/2007 7 Male 71 lb 3/9/2007 Physician Spain
Primary
Concomitant
Prescribed Overdose Other Serious Female 3/23/2007 Consumer United States
Primary
Concomitant
Pseudolymphoma Hospitalization 1/15/2004 59 Female 3/29/2007 Consumer France
Primary
Secondary
Mycosis Fungoides Hospitalization 1/15/2004 62 Female 3/28/2007 France
Primary
Secondary
Visual Disturbance Hospitalization 11/1/2006 52 Female 4/6/2007 United States
Primary
Secondary
Concomitant
Sleep Apnoea Syndrome Hospitalization 2/15/2007 56 Female 5/9/2007 Consumer United States
Primary
Concomitant
Rash Papular Other Serious 7/24/2007 76 Female 110 lb 7/26/2007 Pharmacist United States
Primary
Concomitant
Thrombocytopenia Life Threatening 6/20/2007 93 Female 8/2/2007 Consumer France
Primary
Concomitant
Tremor Hospitalization 5/7/2006 1 Female 8/31/2007 Austria
Primary
Secondary
Application Site Reaction Female 265 lb 9/11/2007 Consumer United States
Primary
Concomitant
Application Site Reaction 46 Female 181 lb 9/11/2007 Consumer United States
Primary
Concomitant
Vomiting Hospitalization 51 Female 180 lb 9/18/2007 Consumer United States
Primary
Concomitant
Thrombocytopenia Other Serious 22 Female 154 lb 9/24/2007 Physician Australia
Primary
Concomitant
Vertigo Hospitalization 9/15/2007 37 Male 10/22/2007 Physician France
Primary
Concomitant
Vomiting Hospitalization 1/1/2007 4 Male 24 lb 11/8/2007 Consumer France
Primary
Secondary
Concomitant
Tremor Hospitalization 10/9/2007 Female 11/15/2007 United Kingdom
Primary
Secondary
Concomitant
Suicidal Ideation Other Serious 1/1/2006 30 Male 11/21/2007 Consumer United States
Primary
Concomitant
White Blood Cell Count Decreased Other Serious 7/1/2005 54 Female 145 lb 11/13/2007 Consumer Canada
Primary
Secondary
Concomitant
Tremor Hospitalization 10/9/2007 11/21/2007 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Hypoglycaemia Other Serious 68 Female 10/22/2007 United States
Primary
Secondary
Concomitant
Mental Disorder Other Serious 12/1/2007 Female 250 lb 1/7/2008 United States
Primary
Concomitant
Pharmaceutical Product Complaint Other Serious 1/19/2008 Male 151 lb 1/19/2008 Pharmacist United States
Primary
Concomitant
Neurotoxicity Other Serious 11/6/2007 63 Male 2/5/2008 Pharmacist United States
Primary
Concomitant
Swollen Tongue Hospitalization 1/5/2008 74 Female 2/13/2008 Consumer Norway
Primary
Concomitant
Swollen Tongue Hospitalization 1/5/2008 74 Female 2/13/2008 Consumer Norway
Primary
Concomitant
Suicidal Ideation Other Serious 1/1/2006 30 Male 2/20/2008 Consumer United States
Primary
Concomitant
Drug Interaction Death 2/3/2008 82 Female 3/4/2008 Consumer Norway
Primary
Secondary
Concomitant
Drug Interaction Death 2/3/2008 82 Female 3/11/2008 Consumer Norway
Primary
Secondary
Concomitant
Suicidal Ideation Hospitalization 7/1/2007 Female 187 lb 3/11/2008 United States
Primary
Concomitant
Weight Increased 11/29/2007 59 Female 187 lb 3/4/2008 United States
Primary
Concomitant
Bone Marrow Failure Hospitalization 1/28/2008 58 Female 3/24/2008 Consumer France
Primary
Secondary
Concomitant
White Blood Cell Count Increased Hospitalization 6/1/2007 4/1/2008 Physician United States
Primary
Secondary
Concomitant
Bone Marrow Failure Hospitalization 1/28/2008 Female 4/7/2008 Other Health Professional Germany
Primary
Secondary
Concomitant
Purpura Life Threatening 1/5/2008 38 Female 4/9/2008 Physician Australia
Primary
Concomitant
Bone Marrow Failure Hospitalization 1/28/2008 58 Female 4/18/2008 Consumer France
Primary
Secondary
Concomitant
Bone Marrow Failure Hospitalization 1/28/2008 58 Female 5/8/2008 Consumer France
Primary
Secondary
Concomitant
Tremor Other Serious 11/14/2006 70 Female 5/9/2008 Physician United States
Primary
Secondary
Concomitant
Skin Disorder Other Serious 9/1/2006 49 Female 5/16/2008 Consumer United States
Primary
Secondary
Concomitant
Medication Error Other Serious 1/1/2008 Female 164 lb 5/16/2008 Consumer United States
Primary
Concomitant
Suicidal Ideation Hospitalization 7/1/2007 Female 187 lb 5/20/2008 United States
Primary
Concomitant
Bone Marrow Failure Hospitalization 1/28/2008 58 Female 6/3/2008 Consumer France
Primary
Secondary
Concomitant
Convulsion Other Serious 4/12/2008 Female 191 lb 6/6/2008 Physician United States
Primary
Concomitant
Skull Malformation Congenital Anomaly 7/23/2007 Male 6 lb 6/3/2008 Physician France
Primary
Secondary
Concomitant
Pregnancy Other Serious 22 Female 6/3/2008 Physician France
Primary
Secondary
Concomitant
Skull Malformation Congenital Anomaly 11/17/2006 Male 6 lb 6/10/2008 Consumer France
Primary
Secondary
Concomitant
Pregnancy Other Serious 22 Female 6/9/2008 Physician France
Primary
Secondary
Concomitant
Skull Malformation Congenital Anomaly 7/23/2007 Male 6 lb 6/10/2008 France
Primary
Secondary
Concomitant
Skull Malformation Congenital Anomaly 7/23/2007 Male 6 lb 6/13/2008 Other Health Professional France
Primary
Secondary
Concomitant
Skull Malformation Congenital Anomaly 11/17/2006 Male 6 lb 6/25/2008 Consumer France
Primary
Secondary
Concomitant
Vertigo Hospitalization 9/15/2007 37 Male 152 lb 6/20/2008 France
Primary
Concomitant
Plantar Fasciitis Hospitalization 1/1/2004 Female 6/27/2008 Consumer United States
Primary
Concomitant
Weight Decreased Other Serious 9/1/2006 49 Female 7/7/2008 Consumer United States
Primary
Secondary
Concomitant
Vomiting 7/14/2008 17 Female 249 lb 7/24/2008 Consumer United States
Primary
Concomitant
Cellulitis Hospitalization 6/3/2007 5 Male 7/24/2008 Physician United States
Primary
Concomitant
Neutrophilia Other Serious 54 Female 7/25/2008 Consumer Canada
Primary
Secondary
Concomitant
Tearfulness Hospitalization 7/1/2008 46 Female 249 lb 7/28/2008 Consumer United States
Primary
Concomitant
Weight Fluctuation Hospitalization 10/1/2007 57 Female 7/29/2008 Consumer United States
Primary
Concomitant
Weight Increased Hospitalization Female 8/4/2008 Consumer United States
Primary
Secondary
Concomitant
Suicidal Ideation Other Serious 7/29/2008 20 Female 130 lb 7/31/2008 Other Health Professional United States
Primary
Concomitant
Weight Decreased Other Serious 9/1/2006 Female 200 lb 8/8/2008 Physician United States
Primary
Secondary
Concomitant
Overdose Other Serious 8/3/2008 82 Female 8/14/2008 Consumer United States
Primary
Concomitant
Vaginal Haemorrhage Other Serious 1/1/2008 Female 235 lb 9/10/2008 Consumer United States
Primary
Concomitant
Tremor Hospitalization 10/9/2007 58 Female 9/26/2008 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Cellulitis Hospitalization 6/3/2007 5 Male 10/29/2008 Physician United States
Primary
Concomitant
Urticaria Other Serious 79 Female 11/3/2008 Consumer New Zealand
Primary
Concomitant
Stevens-johnson Syndrome Other Serious 70 Female 11/24/2008 Physician United States
Primary
Concomitant
Pruritus Hospitalization 8/28/2008 70 Female 11/26/2008 Physician United States
Primary
Concomitant
Rash Other Serious 6/23/2008 42 Female 12/5/2008 Consumer United States
Primary
Concomitant
Upper Limb Fracture Hospitalization 1/1/2006 77 Female 12/16/2008 Consumer United States
Primary
Concomitant
Stevens-johnson Syndrome Hospitalization 1/1/2008 70 Female 1/6/2009 Physician United States
Primary
Concomitant
Weight Increased Other Serious 22 Female 1/7/2009 Consumer Australia
Primary
Concomitant
Urine Odour Abnormal Female 1/13/2009 Consumer United States
Primary
Interacting
Cellulitis Hospitalization 6/3/2007 5 Male 2/12/2009 Physician United States
Primary
Concomitant
Syncope Hospitalization 9/23/2008 65 Female 2/20/2009 Other Health Professional France
Primary
Concomitant
Weight Decreased 12/1/2006 54 Female 2/27/2009 Consumer United States
Primary
Concomitant
Rash 1/1/2008 45 Female 2/27/2009 Consumer United States
Primary
Concomitant
Rash 3/1/2008 66 Female 2/27/2009 Consumer United States
Primary
Concomitant
Metrorrhagia 12/24/2007 49 Female 300 lb 2/27/2009 Consumer United States
Primary
Concomitant
Rash Other Serious 3/9/2008 46 Female 2/27/2009 Consumer United States
Primary
Concomitant
Tinnitus 4/10/2008 57 Female 2/27/2009 Consumer United States
Primary
Concomitant
Sunburn 5/2/2008 49 Male 2/27/2009 Consumer United States
Primary
Concomitant
Visual Impairment 5/8/2008 56 Female 2/27/2009 Consumer United States
Primary
Concomitant
Dyskinesia 6/1/2008 92 Female 2/27/2009 Consumer United States
Primary
Concomitant
Diarrhoea 7/10/2008 47 Female 2/27/2009 Consumer United States
Primary
Concomitant
Gastric Haemorrhage Other Serious 7/16/2008 55 Female 2/27/2009 Consumer United States
Primary
Concomitant
Rash Vesicular 4/1/2008 41 Female 2/27/2009 Consumer United States
Primary
Concomitant
Inflammation 8/1/2008 46 Male 2/27/2009 Consumer United States
Primary
Concomitant
Visual Impairment Other Serious 10/1/2007 48 Female 2/27/2009 Consumer United States
Primary
Concomitant
Type 2 Diabetes Mellitus Other Serious 9/4/2002 50 Male 290 lb 3/26/2009 Other Health Professional United States
Primary
Concomitant
Interacting
Sinus Bradycardia Other Serious 11/24/2008 92 Male 4/1/2009 Other Health Professional Germany
Primary
Secondary
Concomitant
Ventricular Tachycardia Other Serious 2/1/2005 48 Female 278 lb 4/16/2009 United States
Primary
Concomitant
Visual Impairment Other Serious 10/1/2007 48 Female 4/27/2009 Consumer United States
Primary
Concomitant
Ventricular Tachycardia Other Serious 2/4/2005 48 Female 245 lb 4/28/2009 United States
Primary
Concomitant
Epilepsy Other Serious 1/1/2008 83 Female 4/27/2009 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Product Substitution Issue Other Serious 1/1/2008 83 Female 5/5/2009 United Kingdom
Primary
Secondary
Concomitant
Epilepsy Other Serious 1/1/2008 83 Female 5/14/2009 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Epilepsy Hospitalization 1/1/2008 83 Female 5/21/2009 United Kingdom
Primary
Secondary
Concomitant
Epilepsy Other Serious 1/1/2008 83 Female 6/4/2009 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Overdose Death 11/5/2005 49 Male 6/8/2009 Physician Sweden
Primary
Concomitant
Product Substitution Issue Hospitalization 1/1/2008 83 Female 6/8/2009 United Kingdom
Primary
Secondary
Concomitant
Death Death 8/23/2008 Male 6/30/2009 United States
Primary
Concomitant
Vomiting Hospitalization 5/27/2009 Female 7/6/2009 Consumer Norway
Primary
Concomitant
Urticaria Life Threatening 5/1/2009 35 Female 7/16/2009 Consumer United States
Primary
Concomitant
Weight Increased Other Serious 2/25/2008 45 Female 176 lb 7/17/2009 United States
Primary
Concomitant
Type 2 Diabetes Mellitus Other Serious 5/12/2003 48 Female 203 lb 7/23/2009 United States
Primary
Secondary
Concomitant
Tremor Other Serious 7/1/2009 46 Female 7/23/2009 Consumer United States
Primary
Concomitant
Urticaria Life Threatening 5/1/2009 35 Female 8/3/2009 Consumer United States
Primary
Concomitant
Urine Ketone Body Present Other Serious 7/25/2009 Female 9/4/2009 Physician United States
Primary
Concomitant
Productive Cough Other Serious 2/3/2009 70 Female 163 lb 9/14/2009 United States
Primary
Concomitant
Ventricular Tachycardia Other Serious 2/4/2005 48 Female 245 lb 9/21/2009 United States
Primary
Concomitant
Potentiating Drug Interaction Disability 3/23/2009 43 Female 9/15/2009 Pharmacist United States
Primary
Secondary
Concomitant
Pancreatitis Other Serious Female 9/23/2009 United States
Primary
Concomitant
Pancreatitis Acute Other Serious 1/1/1999 32 Male 375 lb 9/23/2009 United States
Primary
Concomitant
Type 2 Diabetes Mellitus 1/1/2000 44 Female 250 lb 9/23/2009 United States
Primary
Concomitant
Suicidal Ideation Other Serious 3/1/2009 47 Female 200 lb 9/24/2009 Consumer United States
Primary
Secondary
Concomitant
Weight Increased 49 Female 9/24/2009 Consumer United States
Primary
Concomitant

Drug Data